| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/30/2006 | EP1694318A1 (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist |
| 08/30/2006 | EP1694317A1 Copper antagonist compounds |
| 08/30/2006 | EP1694316A1 Memantine for the prevention or reduction of suicidality and for treatment of major depression associated with suicidality |
| 08/30/2006 | EP1694315A2 Glycopegylated factor ix |
| 08/30/2006 | EP1694314A1 Treatment and preventions of asthma |
| 08/30/2006 | EP1694313A2 Tellurium derivatives for prevention and treatment of neurodegenerative processes |
| 08/30/2006 | EP1694305A2 Pharmaceutical compositions comprising lercanidipine |
| 08/30/2006 | EP1694304A2 Azithromycin multiparticulate dosage forms by liquid-based processes |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1694300A2 Dosing methods for beta-d-2',3'-dideoxy-2',3' -didehydro-5-fluorocytidine antiviral therapy |
| 08/30/2006 | EP1694299A2 Method for drug loading in liposomes |
| 08/30/2006 | EP1694297A2 Controlled release analgesic suspensions |
| 08/30/2006 | EP1694296A1 Injectable composition |
| 08/30/2006 | EP1694294A1 Pharmaceutical compositions with synchronized solubilizer release |
| 08/30/2006 | EP1694291A2 Endoparasiticidal agents for topical application |
| 08/30/2006 | EP1694281A2 Biphenyl compounds and methods |
| 08/30/2006 | EP1694277A2 Methods of administering water-soluble prodrugs of propofol for extended sedation |
| 08/30/2006 | EP1694260A1 Methods and compositions for deterring abuse of opioid containing dosage forms |
| 08/30/2006 | EP1694242A1 Pharmaceutical formulations of camptothecins and process for making same |
| 08/30/2006 | EP1694192A2 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 08/30/2006 | EP1660067A4 Methods and materials for treating conditions associated with metabolic disorders |
| 08/30/2006 | EP1646328A4 Treatment of dependence withdrawal |
| 08/30/2006 | EP1608407B1 Dispersible formulation of an anti-inflammatory agent |
| 08/30/2006 | EP1603907B1 Substituted pyrido(1,2-a)pyrimidines and their use as nos inhibitors |
| 08/30/2006 | EP1562596B1 Derivatives of pyridinalkyl-amonoalkyl-1h-indole inhibiting receptors 5-ht and recapture of serotonin which can be used as antidepressant and anxiolitic |
| 08/30/2006 | EP1543002B1 Preparation of 1h-imidazo 4,5-c|quinolin-4-amines via1h-imidazo 4,5-c|quinolin-4-phthalimide intermediates |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1505966A4 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors |
| 08/30/2006 | EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | EP1478231B1 Synergistic mixtures of 1,2-alkane diols |
| 08/30/2006 | EP1458682B1 1,4-dihydro-1,4-diphenylpyridine derivatives |
| 08/30/2006 | EP1442030B1 Thiopene- amd thiazolesulfonamides as antineoplastic agents |
| 08/30/2006 | EP1439885B1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 08/30/2006 | EP1436292B1 5-methoxy-8-aryl-¬1,2,4|triazolo¬1,5-a|pyridine derivatives as adenosine receptor antagonists |
| 08/30/2006 | EP1429758A4 Photodynamic porphyrin antimicrobial agents |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1421198A4 Cell-based high-throughput screening methods |
| 08/30/2006 | EP1421086B1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA a|NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/30/2006 | EP1385519B1 Compounds for treating inflammatory diseases |
| 08/30/2006 | EP1383772B1 Nitrogen-based camptothecin derivatives |
| 08/30/2006 | EP1377298B1 Exemestane for treating hormono-dependent disorders |
| 08/30/2006 | EP1373250B1 Viologen linked acridine based molecule and process for the preparation thereof |
| 08/30/2006 | EP1359914B1 Novel therapeutic use of a thienylcyclohexylamine derivative for treating pain |
| 08/30/2006 | EP1345924B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 08/30/2006 | EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders |
| 08/30/2006 | EP1333842B1 Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders |
| 08/30/2006 | EP1322660B1 17alpha-fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP1317429B1 Amidine inhibitors of serine proteases |
| 08/30/2006 | EP1276459B1 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 08/30/2006 | EP1272183B1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/30/2006 | EP1147124B1 Steroid sulfatase inhibitors and methods for making and using the same |
| 08/30/2006 | EP1143958B1 Pharmaceutical composition and use of rnsaid for treating inflammation |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | EP1084214B1 Contaminant reduced marine oil |
| 08/30/2006 | EP1066042B1 Steroidal saponins for treating alzheimer's disease |
| 08/30/2006 | EP1020439B1 Cetp activity inhibitors |
| 08/30/2006 | EP0994100B1 3-anilino-2-cycloalkenone derivates |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0946221B1 Use of taurolidine or taurultam for the prevention and the treatment of infections in delivery systems |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0793489B9 Use of statin for the treatment of skin disorders |
| 08/30/2006 | EP0755270B1 Microcapsules, method of making and their use |
| 08/30/2006 | CN1826381A Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 08/30/2006 | CN1826360A Thermosensitive polymers for therapeutic use and methods of preparation |
| 08/30/2006 | CN1826348A Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds |
| 08/30/2006 | CN1826347A Indolopyrrolocabazole derivative and antitumor agent |
| 08/30/2006 | CN1826346A N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 08/30/2006 | CN1826345A Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 08/30/2006 | CN1826344A (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 08/30/2006 | CN1826343A Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 08/30/2006 | CN1826340A Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826338A Therapeutic agent for senile dementia |
| 08/30/2006 | CN1826336A Cyclohexanecarboxylic acid compound |
| 08/30/2006 | CN1826335A Process for producing 1,2,4-triazole compound and intermediate therefor |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/30/2006 | CN1826330A Combretastatin derivatives with cytotoxic action |
| 08/30/2006 | CN1826324A Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 08/30/2006 | CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 08/30/2006 | CN1826322A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826319A Aryl-heteroaromatic compounds, compositions comprising them and use |
| 08/30/2006 | CN1826318A Stable modifications of tegaserod hydrogen maleate |
| 08/30/2006 | CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
| 08/30/2006 | CN1826308A Fluorocombretastatin and derivatives thereof |
| 08/30/2006 | CN1826140A Combination therapy for the treatment of bacterial infections |
| 08/30/2006 | CN1826128A Turmeric-containing composition |
| 08/30/2006 | CN1826127A Use of a lupeol-rich extract to make a pharmaceutical or cosmetic composition for treating or preventing degeneration of dermal, cartilage and/or gingival connective tissue |
| 08/30/2006 | CN1826124A Combinations of a cathepsin K inhibitor and a bisphophonate in the treatment of bone metastasis tumor, tumor growth and tumor-induced bone loss |
| 08/30/2006 | CN1826123A Acute inflammatory condition treatment |
| 08/30/2006 | CN1826122A Oxidized phospholipids and application in atherosclerosis treatment thereof |
| 08/30/2006 | CN1826121A Method for modulating calcium ion-release-activated calcium ion channels |